Global Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device Market Strategic Research Report

Scope of the Report

The global Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device market size is predicted to grow from US$ 375 million in 2025 to US$ 1,711 million in 2032; it is expected to grow at a CAGR of 24.2% from 2026 to 2032.

In 2025, global sales of Joule-Thomson throttling refrigeration cryoablation devices reached 476 units, with an average price of $806,000 per unit.

Cryoablation refers to a method of freezing diseased tissue through low-temperature technology to achieve in situ inactivation of solid tissue. The working principle is to use low temperature to quickly cool down the diseased tissue to destroy cells, causing cell necrosis or apoptosis, thereby achieving the purpose of treatment. Since cryoablation uses the physical method of energy exchange to achieve the purpose of treatment, its trauma and side effects to the human body are much lower than conventional radiotherapy and chemotherapy, so it is hailed as a "green therapy".

In the 1990s, Endocare, an American company, developed a new type of cryotherapy equipment using the Joule-Thomson throttling refrigeration principle. The equipment uses argon throttling refrigeration and helium throttling heating rewarming to achieve rapid freezing treatment and rewarming needle removal. It is used for ablation treatment of various solid tumors such as lung cancer and liver cancer. China has become the most active country in the world in clinical research on cryoablation tumors.

The raw material system for these devices falls into two main categories: the main unit and single-use consumables. Core components of the main unit include a high-precision gas control system (pressure sensors, flow control valves, and solenoid valve assemblies), a touchscreen control unit, vacuum-insulated gas transmission lines, and an aluminum alloy or stainless steel chassis frame. The gas control valve assemblies and sensors require extremely high precision in manufacturing; manufacturers often employ a single-supplier strategy to meet FDA, CE, and NMPA regulatory requirements. As the core consumable, the cryoablation needle comprises materials such as the needle tip (Inconel 625 nickel-chromium alloy for MRI-compatible versions; AISI 316L stainless steel for non-MRI versions), polyurethane catheters, polyoxymethylene (POM) connectors, vacuum insulation materials, and sterile packaging. Additionally, the system requires high-pressure argon and helium cylinders along with pressure-reducing adapters to supply the refrigerants.

Regarding cost structure, this type of equipment follows a classic "razor-and-blade" business model. Although the main unit sells for hundreds of thousands of dollars, profits are primarily derived from the high-margin single-use cryoablation needles. The end-user price for a needle ranges from approximately 8,000 to 18,800 RMB, while raw material costs (metal needle tubes, polymer catheters, insulation materials, etc.) account for only 10–20% of the selling price. Major cost drivers include precision manufacturing processes (complex procedures such as vacuum-exhaust welding and stepped-hole sealing), investment in sterile production environments, regulatory compliance costs for Class III medical devices (registration, clinical validation, and quality systems), and the amortization of R&D expenses for novel intelligent temperature control algorithms. In terms of the cost breakdown for the main unit, electronic control systems account for approximately 30–40%, precision gas piping for 20–25%, software systems for 15–20%, and the chassis structure for 10–15%. As many key components rely on single-source suppliers, supply chain risk is high; upstream capacity constraints or quality issues can directly impact the production of the complete unit and clinical supply.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device market?

What factors are driving Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device market opportunities vary by end market size?

How does Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device break out by Type, by Application?

This report presents a comprehensive overview of the global Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Liquid Nitrogen
• Argon and Helium
• Carbon Dioxide and Nitrous Oxide
• Others

Segment by Probe Diameter

• 1.3-1.5mm
• 1.7mm
• 2.4-3.5mm

Segment by Treatment Method

• Percutaneous Puncture
• Laparoscopic/Endoscopic

Segment by Application

• Tumor Treatment
• Heart Treatment
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Joule-Thomson Throttling Refrigeration Cryotherapy Ablation Device market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Tumor Treatment, Heart Treatment, Others evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact